CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

As you might know, CVS Health Corporation (NYSE:CVS) recently reported its third-quarter numbers. Results overall were not great, with earnings of US$0.07 per share falling drastically short of ...

In 2024, retail health care faced significant disruption as industry giants like Walgreens, CVS and Walmart reevaluated their ...

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, Steve Nelson, a former UnitedHealthcare CEO.

Leverage Ratio: Approximately 4.6 times. CVS Health Corp (NYSE:CVS) achieved a record high retail pharmacy script share of 27.3%, indicating strong market presence. The company introduced Simple ...

CVS Health on Wednesday posted a miss in third-quarter profit and named executives for two key divisions CVS Health fell short on third-quarter profit, but it posted strong sales and the health ...